journal article·2024-05

In Situ Self‐Aggregation of Spirulina Skeleton Fibers Enhances the Efficacy of Anti‐Tumor Thermal Immunotherapy

Yong‐Dan Qi, Ze‐Nan Zhuang, Si‐Min Zeng, Ying Tang, Han Cheng, Si‐Xue Cheng, Xian‐Zheng Zhang

Advanced Functional Materials· Volume 34· Issue 19
Publisher page

Abstract

Abstract The lack of broad‐spectrum tumor antigens, limited immunogenicity of antigens, and immunosuppressive microenvironment in tumors have impeded the development of cancer vaccines. To address this issue, a vaccine platform is developed based on Spirulina skeleton fibers loaded with gold (Au) nanoparticles (Au@E‐SP). Upon subcutaneous administration, Au@E‐SP self‐aggregates in situ and forms a 3D vaccine scaffold owing to its elongated and helical architecture. Through the aggregation of Au@E‐SP, Au nanoparticles are concentrated, which significantly enhances the local photothermal effect and releases more tumor‐associated antigens. In addition, the retained E‐SP serves as a natural immune adjuvant that sustainably reverses the immunosuppressive microenvironment in vivo. Combining these advantages, the vaccines induce a potent anti‐tumor immune response, effectively inhibiting tumor recurrence and metastasis. This strategy utilizes microalgae as a self‐adjuvant vaccine, providing a promising avenue for further research in tumor immunotherapy.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Nanoplatforms for cancer theranostics · Immunotherapy and Immune Responses · Immune cells in cancer

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Key Laboratory of Biomedical Polymers of Ministry of Education & Department of Chemistry Wuhan University Wuhan 430072 P. R. China

Funding

National Natural Science Foundation of China

References (60)

Show source-provided references
1. 10.1016/j.cell.2017.01.01710.1016/j.cell.2017.01.017 ↗
2. 10.1038/s41392-022-01136-210.1038/s41392-022-01136-2 ↗
3. 10.3390/ijms2101017010.3390/ijms21010170 ↗
4. 10.1038/s41571-021-00473-510.1038/s41571-021-00473-5 ↗
5. 10.1126/science.aar406010.1126/science.aar4060 ↗
6. 10.1038/nrc393010.1038/nrc3930 ↗
7. 10.1038/s41563-018-0091-810.1038/s41563-018-0091-8 ↗
8. 10.1038/nri286810.1038/nri2868 ↗
9. 10.1038/s41568-021-00346-010.1038/s41568-021-00346-0 ↗
10. 10.1016/j.immuni.2010.10.00210.1016/j.immuni.2010.10.002 ↗
11. 10.1002/1097-4652(200102)186:2<169::AID-JCP1023>3.0.CO;2-H10.1002/1097-4652(200102)186:2<169::AID-JCP1023>3.0.CO;2-H ↗
12. 10.1158/1078-0432.CCR-10-312610.1158/1078-0432.CCR-10-3126 ↗
13. 10.1517/14728214.13.2.29510.1517/14728214.13.2.295 ↗
14. 10.1038/s41568-021-00397-310.1038/s41568-021-00397-3 ↗
15. 10.1038/s41591-021-01233-910.1038/s41591-021-01233-9 ↗
16. 10.1038/s41571-020-00460-210.1038/s41571-020-00460-2 ↗
17. 10.1038/s41467-022-33831-710.1038/s41467-022-33831-7 ↗
18. 10.1016/j.ccell.2022.10.01310.1016/j.ccell.2022.10.013 ↗
19. 10.1038/nrc.2016.1610.1038/nrc.2016.16 ↗
20. 10.1038/s41467-022-32645-x10.1038/s41467-022-32645-x ↗
21. 10.1038/s41565-022-01125-010.1038/s41565-022-01125-0 ↗
22. 10.1146/annurev-immunol-032712-10000810.1146/annurev-immunol-032712-100008 ↗
23. 10.1002/adma.20190262610.1002/adma.201902626 ↗
24. 10.1002/adma.20221045210.1002/adma.202210452 ↗
25. Habib A. · Iran. J. Immunol. · 2023 · 20 · 1
26. 10.1080/21691401.2018.151394110.1080/21691401.2018.1513941 ↗
27. 10.1360/972012-72010.1360/972012-720 ↗
28. 10.1038/nbt.307110.1038/nbt.3071 ↗
29. 10.1021/acsnano.3c0237310.1021/acsnano.3c02373 ↗
30. 10.1038/s41467-021-27750-210.1038/s41467-021-27750-2 ↗
31. 10.1126/science.aar691810.1126/science.aar6918 ↗
32. 10.1038/s41578-021-00399-510.1038/s41578-021-00399-5 ↗
33. 10.1016/S0264-410X(00)00354-610.1016/S0264-410X(00)00354-6 ↗
34. 10.1016/j.biomaterials.2021.12129710.1016/j.biomaterials.2021.121297 ↗
35. 10.1002/adma.20210925410.1002/adma.202109254 ↗
36. 10.1002/VIW.2020018910.1002/VIW.20200189 ↗
37. 10.1038/s41587-022-01249-710.1038/s41587-022-01249-7 ↗
38. 10.1002/adtp.20200010710.1002/adtp.202000107 ↗
39. 10.1021/acsami.8b1558610.1021/acsami.8b15586 ↗
40. 10.1038/s41467-022-28744-410.1038/s41467-022-28744-4 ↗
41. 10.1126/sciadv.abi926510.1126/sciadv.abi9265 ↗
42. 10.1016/j.algal.2018.07.01310.1016/j.algal.2018.07.013 ↗
43. Ali S. K. · Int. J. Pharm. Pharm. Sci. · 2012 · 4 · 9
44. 10.21037/tcr.2019.06.1310.21037/tcr.2019.06.13 ↗
45. 10.1016/S1567-5769(01)00166-710.1016/S1567-5769(01)00166-7 ↗
46. 10.1586/erv.12.3810.1586/erv.12.38 ↗
47. 10.1128/CVI.00036-1010.1128/CVI.00036-10 ↗
48. 10.1016/j.biomaterials.2021.12072410.1016/j.biomaterials.2021.120724 ↗
49. 10.1038/s41571-022-00717-y10.1038/s41571-022-00717-y ↗
50. 10.1126/sciadv.abo528510.1126/sciadv.abo5285 ↗
51. 10.1038/s41551-023-01014-410.1038/s41551-023-01014-4 ↗
52. 10.2147/IJN.S23378910.2147/IJN.S233789 ↗
53. 10.1021/acs.chemrev.2c0091410.1021/acs.chemrev.2c00914 ↗
54. 10.1038/s41579-023-00862-w10.1038/s41579-023-00862-w ↗
55. 10.3109/1743539090347146310.3109/17435390903471463 ↗
56. 10.1016/j.ccell.2023.01.00910.1016/j.ccell.2023.01.009 ↗
57. 10.1007/BF0039566410.1007/BF00395664 ↗
58. 10.1016/j.semcdb.2009.06.00210.1016/j.semcdb.2009.06.002 ↗
59. 10.1016/j.yexmp.2006.06.00710.1016/j.yexmp.2006.06.007 ↗
60. 10.1007/s10856-017-5949-910.1007/s10856-017-5949-9 ↗